High-risk human papillomavirus in non-melanoma skin lesions from renal allograft recipients and immunocompetent patients

British Journal of Cancer

Volumn 104, Issue 8, 2011, Pages 1334-1341

  Reuschenbach, M ^a,b   Tran, T ^a   Faulstich, F ^a,b   Hartschuh, W ^a   Vinokurova, S ^a,b   Kloor, M ^a,b   Krautkramer E ^a   Zeier, M ^a   Von Knebel Doeberitz, M ^a,b   Sommerer, C ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

human papillomavirus; immunosuppression; non melanoma skin cancer; p16 INK4a; renal transplantation

Indexed keywords

PROTEIN P16; PROTEIN P53; RETINOBLASTOMA PROTEIN; VIRUS DNA;

ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOCOMPETENCE; KIDNEY ALLOGRAFT; MALE; MELANOMA; PREVALENCE; PRIORITY JOURNAL; PROPHYLAXIS; SKIN CANCER; SQUAMOUS CELL CARCINOMA; SQUAMOUS EPITHELIUM; UTERINE CERVIX; VIRUS ONCOGENE; WART VIRUS;

ADULT; AGED; AGED, 80 AND OVER; ALPHAPAPILLOMAVIRUS; CARCINOMA, SQUAMOUS CELL; DNA, VIRAL; FEMALE; HUMANS; IMMUNOCOMPETENCE; IMMUNOCOMPROMISED HOST; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; RISK FACTORS; SKIN NEOPLASMS; STAPHYLOCOCCAL SKIN INFECTIONS; TRANSPLANTATION, HOMOLOGOUS;

EID: 79954435764     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2011.95     Document Type: Article

References (36)

1. Alam M, Ratner D (2001) Cutaneous squamous-cell carcinoma. N Engl J Med 344: 975-983 (Pubitemid 32240317)
2. Benjamin CL, Melnikova VO, Ananthaswamy HN (2008) P53 protein and pathogenesis of melanoma and nonmelanoma skin cancer. Adv Exp Med Biol 624: 265-282
3. Blokx WA, de Jong EM, de Wilde PC, Bulten J, Link MM, Ruiter DJ, van de Kerkhof PC (2003) P16 and p53 expression in (pre)malignant epidermal tumors of renal transplant recipients and immunocompetent individuals. Mod Pathol 16: 869-878 (Pubitemid 37152016)
4. Boukamp P (2005) Non-melanoma skin cancer: what drives tumor development and progression? Carcinogenesis 26: 1657-1667 (Pubitemid 41487981)
5. Brakstad OG, Aasbakk K, Maeland JA (1992) Detection of Staphylococcus aureus by polymerase chain reaction amplification of the nuc gene. J Clin Microbiol 30: 1654-1660
6. Cheah PL, Looi LM (2002) P53 immunohistochemical expression: messages in cervical carcinogenesis. Pathology 34: 326-331
7. de Villiers EM, Lavergne D, McLaren K, Benton EC (1997) Prevailing papillomavirus types in non-melanoma carcinomas of the skin in renal allograft recipients. Int J Cancer 73: 356-361 (Pubitemid 27508898)
8. Euvrard S, Kanitakis J, Claudy A (2003) Skin cancers after organ transplantation. N Engl J Med 348: 1681-1691 (Pubitemid 36459475)
9. Forslund O, Ly H, Reid C, Higgins G (2003) A broad spectrum of human papillomavirus types is present in the skin of Australian patients with non-melanoma skin cancers and solar keratosis. Br J Dermatol 149: 64-73 (Pubitemid 36966512)
10. Geradts J, Kratzke RA, Niehans GA, Lincoln CE (1995) Immunohisto-chemical detection of the cyclin-dependent kinase inhibitor 2/multiple tumor suppressor gene 1 (CDKN2/MTS1) product p16INK4A in archival human solid tumors: correlation with retinoblastoma protein expression. Cancer Res 55: 6006
11. Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM (2007) Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet 370: 59-67 (Pubitemid 47017468)
12. Harwood CA, Surentheran T, McGregor JM, Spink PJ, Leigh IM, Breuer J, Proby CM (2000) Human papillomavirus infection and non-melanoma skin cancer in immunosuppressed and immunocompetent individuals. J Med Virol 61: 289-297 (Pubitemid 30368527)
13. Iftner A, Klug SJ, Garbe C, Blum A, Stancu A, Wilczynski SP, Iftner T (2003) The prevalence of human papillomavirus genotypes in nonmelanoma skin cancers of nonimmunosuppressed individuals identifies high-risk genital types as possible risk factors. Cancer Res 63: 7515-7519 (Pubitemid 37413496)
14. Ishida H, Kumakiri M, Ueda K, Lao LM, Yanagihara M, Asamoto K, Imamura Y, Noriki S, Fukuda M (2001) Comparative histochemical study of Bowen's disease and actinic keratosis: preserved normal basal cells in Bowen's disease. Eur J Histochem 45: 177-190 (Pubitemid 33646534)
15. Khleif SN, DeGregori J, Yee CL, Otterson GA, Kaye FJ, Nevins JR, Howley PM (1996) Inhibition of cyclin D-CDK4/CDK6 activity is associated with an E2F-mediated induction of cyclin kinase inhibitor activity. Proc Natl Acad Sci USA 93: 4350-4354
16. Klaes R, Friedrich T, Spitkovsky D, Ridder R, Rudy W, Petry U, Dallenbach-Hellweg G, Schmidt D, Knebel Doeberitz M (2001) Over-expression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer 92: 276-284 (Pubitemid 32225381)
17. Kruse AJ, Bottenberg MJ, Tosserams J, Slangen B, van Marion AM, van Trappen PO (2008) The absence of high-risk HPV combined with specific p53 and p16INK4a expression patterns points to the HPV-independent pathway as the causative agent for vulvar squamous cell carcinoma and its precursor simplex VIN in a young patient. Int J Gynecol Pathol 27: 591-595
18. Kullander J, Forslund O, Dillner J (2009) Staphylococcus aureus and squamous cell carcinoma of the skin. Cancer Epidemiol Biomarkers Prev 18: 472-478
19. Kusters-Vandevelde HV, de Koning MN, Melchers WJ, Quint WG, de Wilde PC, de Jong EM, van de Kerkhof PC, Blokx WA (2009) Expression of p14ARF, p16INK4a and p53 in relation to HPV in (pre-) malignant squamous skin tumours. J Cell Mol Med 13: 2148-2157
20. Kusters-Vandevelde HV, Van Leeuwen A, Verdijk MA, de Koning MN, Quint WG, Melchers WJ, Ligtenberg MJ, Blokx WA (2010) CDKN2A but not TP53 mutations nor HPV presence predict poor outcome in metastatic squamous cell carcinoma of the skin. Int J Cancer 126: 2123-2132
21. Madan V, Lear JT, Szeimies RM (2010) Non-melanoma skin cancer. Lancet 375: 673-685
22. Nindl I, Gottschling M, Stockfleth E (2007) Human papillomaviruses and non-melanoma skin cancer: basic virology and clinical manifestations. Dis Markers 23: 247-259 (Pubitemid 47015794)
23. Nindl I, Meyer T, Schmook T, Ulrich C, Ridder R, Audring H, Sterry W, Stockfleth E (2004) Human papillomavirus and overexpression of P16INK4a in nonmelanoma skin cancer. Dermatol Surg 30: 409-414 (Pubitemid 38524162)
24. Nindl I, Rosl F (2008) Molecular concepts of virus infections causing skin cancer in organ transplant recipients. Am J Transplant 8: 2199-2204
25. Okamoto A, Demetrick DJ, Spillare EA, Hagiwara K, Hussain SP, Bennett WP, Forrester K, Gerwin B, Greenblatt MS, Serrano M (1994) p16INK4 mutations and altered expression in human tumors and cell lines. Cold Spring Harb Symp Quant Biol 59: 49-57
26. Pfister H (2003) Chapter 8: human papillomavirus and skin cancer. J Natl Cancer Inst Monogr 31: 52-56
27. Ramos J, Villa J, Ruiz A, Armstrong R, Matta J (2004) UV dose determines key characteristics of nonmelanoma skin cancer. Cancer Epidemiol Biomarkers Prev 13: 2006-2011 (Pubitemid 40054293)
28. Rubin AI, Chen EH, Ratner D (2005) Basal-cell carcinoma. N Engl J Med 353: 2262-2269 (Pubitemid 41697289)
29. Sano T, Oyama T, Kashiwabara K, Fukuda T, Nakajima T (1998) Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions. Am J Pathol 153: 1741-1748 (Pubitemid 28550662)
30. Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM (1990) The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63: 1129-1136 (Pubitemid 120035062)
31. Schmitt M, Bravo IG, Snijders PJ, Gissmann L, Pawlita M, Waterboer T (2006) Bead-based multiplex genotyping of human papillomaviruses. J Clin Microbiol 44: 504-512 (Pubitemid 43222244)
32. Smith EM, Wang D, Rubenstein LM, Morris WA, Turek LP, Haugen TH (2008) Association between p53 and human papillomavirus in head and neck cancer survival. Cancer Epidemiol Biomarkers Prev 17: 421-427 (Pubitemid 351272796)
33. Stark LA, Arends MJ, McLaren KM, Benton EC, Shahidullah H, Hunter JA, Bird CC (1994) Accumulation of p53 is associated with tumour progression in cutaneous lesions of renal allograft recipients. Br J Cancer 70: 662-667 (Pubitemid 24305593)
34. Stockfleth E, Nindl I, Sterry W, Ulrich C, Schmook T, Meyer T (2004) Human papillomaviruses in transplant-associated skin cancers. Dermatol Surg 30: 604-609 (Pubitemid 38525889)
35. Wu X, Nguyen BC, Dziunycz P, Chang S, Brooks Y, Lefort K, Hofbauer GF, Dotto GP (2010) Opposing roles for calcineurin and ATF3 in squamous skin cancer. Nature 465: 368-372
36. Zur Hausen H (2009) Papillomaviruses in the causation of human cancers - a brief historical account. Virology 384: 260-265